Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc

271Citations
Citations of this article
192Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Neoplastic lesions typically express specific carbohydrate antigens on glycolipids, mucins, and other glycoproteins. Such antigens are often under epigenetic control and are subject to reversion and loss upon therapeutic selective pressure. We report here that two of the most common tumor-associated carbohydrate antigens, Tn and sialyl Tn (STn), result from somatic mutations in the gene Cosmc that encodes a molecular chaperone required for formation of the active T-synthase. Diverse neoplastic lesions, including colon cancer and melanoma-derived cells lines, expressed both Tn and STn antigen due to loss-of-function mutations in Cosmc. In addition, two human cervical cancer specimens that showed expression of the Tn/STn antigens were also found to have mutations in Cosmc and loss of heterozygosity for the cross-linked Cosmc locus. This is the first example of somatic mutations in multiple types of cancers that cause global alterations in cell surface carbohydrate antigen expression. ©2008 American Association for Cancer Research.

Cite

CITATION STYLE

APA

Ju, T., Lanneau, G. S., Gautam, T., Wang, Y., Xia, B., Stowell, S. R., … Cummings, R. D. (2008). Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. Cancer Research, 68(6), 1636–1646. https://doi.org/10.1158/0008-5472.CAN-07-2345

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free